Search Results Search Sort by RelevanceMost Recent Medicine and Society May 2024 Why We Need to Change How We Talk About Infectious Disease Frank Kronenberg, PhD and Sipho Dlamini, MBChB Raising occupational consciousness and critically questioning ahistorical and apolitical uses of "battle" is needed for responding to antimicrobial resistance. AMA J Ethics. 2024;26(5):E390-398. doi: 10.1001/amajethics.2024.390. Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494. Medicine and Society Jun 2024 How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections? Jeannie P. Cimiotti, PhD, RN, Kimberly Adams Tufts, ND, WHNP-BC, Lucia D. Wocial, PhD, RN, HEC-C, and Elizabeth Peter, PhD, RN Some patients’ end-of-life care plans still require good antimicrobial management. AMA J Ethics. 2024;26(6):E486-493. doi: 10.1001/amajethics.2024.486.
Medicine and Society May 2024 Why We Need to Change How We Talk About Infectious Disease Frank Kronenberg, PhD and Sipho Dlamini, MBChB Raising occupational consciousness and critically questioning ahistorical and apolitical uses of "battle" is needed for responding to antimicrobial resistance. AMA J Ethics. 2024;26(5):E390-398. doi: 10.1001/amajethics.2024.390.
Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494.
Medicine and Society Jun 2024 How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections? Jeannie P. Cimiotti, PhD, RN, Kimberly Adams Tufts, ND, WHNP-BC, Lucia D. Wocial, PhD, RN, HEC-C, and Elizabeth Peter, PhD, RN Some patients’ end-of-life care plans still require good antimicrobial management. AMA J Ethics. 2024;26(6):E486-493. doi: 10.1001/amajethics.2024.486.